-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

Sponsor: American Regent, Inc.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Diseases, Therapies, Adverse Events
Friday, December 8, 2023: 11:00 AM-2:00 PM
Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
George M. Rodgers, MD, PhD, Univ. of Utah Medical Center
No relevant conflicts of interest to declare.
Patricia A. Locantore-Ford, MD, Pennsylvania Hospital and Sidharth Anand, MD, UCLA Health
Locantore-Ford: Cardinal Health: Consultancy, Honoraria; Accumen: Consultancy, Current Employment, Membership on an entity's Board of Directors or advisory committees.
There is an the unmet need for educational activities designed to close the gap in knowledge for physicians who treat or manage patients with cancer-related anemia. This program is centered around improving medical practices and patient care for those who are diagnosed with cancer-related iron deficiency anemia and will feature a mix of didactic and discussion sessions. This satellite will aim to provide an overview of pathophysiologic mechanisms and prevalence of cancer-related iron deficiency anemia, current applications of iron supplementation including a breakdown of oral versus IV iron, case discussions, and what oncologists/hematologists can do to address challenges with diagnosis and management of patients.